Tissue sealants and tissue adhesive sales will expand through 2036, with gelatin based sealants holding 62.2% of the product type segment in 2026, driven by established clinical safety profile and superior hemostatic capability. The market was valued at USD 2.06 billion in 2025 and is expected to be worth USD 5 billion by 2036.